EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

被引:184
|
作者
Oppe, Mark [1 ]
Rand-Hendriksen, Kim [2 ,3 ]
Shah, Koonal [4 ]
Ramos-Goni, Juan M. [1 ]
Luo, Nan [5 ]
机构
[1] EuroQol Res Fdn, Rotterdam, Netherlands
[2] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
[3] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[4] Off Hlth Econ, London, England
[5] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2,Block MD1,11-01D, Singapore 117549, Singapore
关键词
STATES WORSE; MODELING VALUATIONS; VALUE SETS; EQ-5D; VALUES; TTO; PREFERENCES; TRANSFORMATION; POPULATION; CHALLENGES;
D O I
10.1007/s40273-016-0404-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
The time trade-off (TTO) valuation technique is widely used to determine utility values of health outcomes to inform quality-adjusted life-year (QALY) calculations for use in economic evaluation. Protocols for implementing TTO vary in aspects such as the trade-off framework, iteration procedure and its administration model and method, training of respondents and interviewers, and quality control of data collection. The most widely studied and utilized TTO valuation protocols are the Measurement and Valuation of Health (MVH) protocol, the Paris protocol and the EuroQol Valuation Technology (EQ-VT) protocol, all developed by members of the EuroQol Group. The MVH protocol and its successor, the Paris protocol, were developed for valuation of EQ-5D-3L health states. Both protocols were designed for a trained interviewer to elicit preferences from a respondent using the conventional TTO framework with a fixed time horizon of 10 years and an iteration procedure combining bisection and titration. Developed for valuation of EQ-5D-5L health states, the EQ-VT protocol adopted a composite TTO framework and made use of computer technology to facilitate data collection. Training and monitoring of interviewers and respondents is a pivotal component of the EQ-VT protocol. Research is underway aiming to further improve the EuroQol protocols, which form an important basis for the current practice of health technology assessment in many countries.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [41] Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States
    Lo, Siu Hing
    Lloyd, Andrew
    Elkhalifa, Shuayb
    Sisic, Zlatko
    van Nooten, Floortje E.
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 231 - 239
  • [42] HEALTH STATES UTILITY VALUES IN OSTEOPOROSIS USING TIME TRADE-OFF
    Kwon, H.
    Bae, G.
    An, J.
    Park, J.
    VALUE IN HEALTH, 2018, 21 : S82 - S82
  • [43] TIME TRADE-OFF HEALTH UTILITY VALUES FOR DEPRESSION: A SYSTEMATIC REVIEW
    Balazs, P.
    Erdosi, D.
    Rencz, F.
    Zemplenyi, A.
    Brodszky, V
    VALUE IN HEALTH, 2022, 25 (01) : S222 - S223
  • [44] A MODIFIED TIME TRADE-OFF EXPERIMENT IN EQ-5D-3L VALUATION WITH FUZZY HEALTH STATES UTILITIES
    Jakubczyk, M.
    Golicki, D.
    VALUE IN HEALTH, 2017, 20 (09) : A755 - A755
  • [45] Differences in Valuation of EQ-5D Health States Between Time Trade-Off and Self-Assessment (MT)
    Lo, Justin
    Palta, Mari
    Vanness, David J.
    QUALITY OF LIFE RESEARCH, 2012, 20 : 81 - 81
  • [46] VALUATION OF THE EQ HEALTH AND WELL-BEING SHORT USING TIME TRADE-OFF AND DISCRETE CHOICE EXPERIMENTS: A FEASIBILITY STUDY
    Mukuria, C.
    Peasgood, T.
    McDool, E.
    Norman, R.
    Rowen, D.
    Brazier, J. E.
    VALUE IN HEALTH, 2022, 25 (12) : S413 - S413
  • [47] Valuation of schizophrenia-related health states by the general population using the AQoL, time trade-off and visual analogue scales
    Adams, J
    Le Reun, C
    Crowley, S
    Nand, V
    Eggleston, A
    Schrover, R
    VALUE IN HEALTH, 2005, 8 (03) : 404 - 404
  • [48] Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States
    Siu Hing Lo
    Andrew Lloyd
    Shuayb Elkhalifa
    Zlatko Sisic
    Floortje E. van Nooten
    PharmacoEconomics - Open, 2022, 6 : 231 - 239
  • [49] Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?
    Yang, Zhihao
    van Busschbach, Jan
    Timman, Reinier
    Janssen, M. F.
    Luo, Nan
    PLOS ONE, 2017, 12 (09):
  • [50] THE UTILITY OF THE TIME TRADE-OFF METHOD IN CANCER-PATIENTS - FEASIBILITY AND PROPORTIONAL TRADE-OFF
    STIGGELBOUT, AM
    KIEBERT, GM
    KIEVIT, J
    LEER, JWH
    HABBEMA, JDF
    DEHAES, JCJM
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (10) : 1207 - 1214